Donepezil: A meta-analysis of individual patient data from randomized controlled trials in the treatment of patients with mild to moderate Alzheimer's disease.

Donepezil: A meta-analysis of individual patient data from randomized controlled trials in the treatment of patients with mild to moderate Alzheimer's disease.

Weitere Versionen anzeigen (2)

Bibliographische Detailangaben
Hauptverfasser:	Perdomo, C, Wilcock, G, Whitehead, A, Evans, J, Birks, J, Pratt, R
Format:	Conference item
Veröffentlicht:	2003

Ähnliche Einträge

Donepezil: A meta-analysis of individual patient data from randomized controlled trials in the treatment of patients with mild to moderate Alzheimer's disease.
von: Pratt, R, et al.
Veröffentlicht: (2001)

Donepezil: A meta-analysis of individual patient data from randomized controlled trials in the treatment of patients with mild to moderate Alzheimer's disease
von: Wilcock, G, et al.
Veröffentlicht: (2001)

Donepezil for the symptomatic treatment of patients with mild to moderate Alzheimer's disease: a meta-analysis of individual patient data from randomised controlled trials.
von: Whitehead, A, et al.
Veröffentlicht: (2004)

Research progress of donepezil for treating mild to moderate Alzheimer's disease
von: Xin-xin LI, et al.
Veröffentlicht: (2017-02-01)

Donepezil for dementia due to Alzheimer's disease
von: Birks, J, et al.
Veröffentlicht: (2018)

The effect of selegiline in the treatment of people with Alzheimer's disease: a meta-analysis of published trials.
von: Wilcock, G, et al.
Veröffentlicht: (2002)

Donepezil and memantine for moderate-to-severe Alzheimer's disease
von: Howard, R, et al.
Veröffentlicht: (2012)

Intepirdine as adjunctive therapy to donepezil for mild‐to‐moderate Alzheimer's disease: A randomized, placebo‐controlled, phase 3 clinical trial (MINDSET)
von: Frederick M. Lang, et al.
Veröffentlicht: (2021-01-01)

A long-term comparison of galantamine and donepezil in the treatment of moderate-to-severe Alzheimer's disease: An intent-to-treat analysis
von: Wilcock, G, et al.
Veröffentlicht: (2003)

Effect of acupuncture with donepezil based on syndrome differentiation on cognitive function in patients with mild-to-moderate Alzheimer’s disease: a study protocol for a multicenter randomized controlled trial
von: Qin-Hui Fu, et al.
Veröffentlicht: (2022-08-01)

Donepezil for the treatment of agitation in Alzheimer's disease.
von: Howard, R, et al.
Veröffentlicht: (2007)

Donepezil for vascular cognitive impairment
von: Malouf, R, et al.
Veröffentlicht: (2004)

Long-term efficacy and safety of galantamine in patients with mild-to-moderate Alzheimer's disease: multicenter trial.
von: Pirttilä, T, et al.
Veröffentlicht: (2004)

Long-term safety and tolerability of donepezil 23 mg in patients with moderate to severe Alzheimer’s disease
von: Tariot Pierre, et al.
Veröffentlicht: (2012-06-01)

Safety and tolerability of donepezil 23 mg in moderate to severe Alzheimer's disease
von: Zou Heng, et al.
Veröffentlicht: (2011-05-01)

Donepezil Combined with Natural Hirudin Improves the Clinical Symptoms of Patients with Mild-to-Moderate Alzheimer's Disease: A 20-Week Open-Label Pilot Study
von: De-qiang Li, Yu-ping Zhou, Han Yang
Veröffentlicht: (2012-01-01)

Donepezil Treatment for Alzheimer’s Disease in Chronic Dialysis Patients
von: Konstantina G. Yiannopoulou, et al.
Veröffentlicht: (2019-09-01)

Personalized prediction of Alzheimer's disease and its treatment effects by donepezil: an individual participant data meta-analysis of eight randomized controlled trials
von: Yoshida, K, et al.
Veröffentlicht: (2022)

Modulation of Brain Activity and Functional Connectivity by Acupuncture Combined With Donepezil on Mild-to-Moderate Alzheimer's Disease: A Neuroimaging Pilot Study
von: Yijun Zhan, et al.
Veröffentlicht: (2022-07-01)

Impact of the CYP2D6 single nucleotide polymorphism on the concentration of and therapeutic response to donepezil in mild-to-moderate Alzheimer's disease
von: Ping-Song Chou, et al.
Veröffentlicht: (2022-01-01)

Acupuncture for patients with mild to moderate Alzheimer’s disease: a randomized controlled trial
von: Yujie Jia, et al.
Veröffentlicht: (2017-12-01)

Efficacy and safety of galantamine in patients with mild to moderate Alzheimer's disease: multicentre randomised controlled trial (vol 321, pg 1445, 2000)
von: Wilcock, G
Veröffentlicht: (2001)

Bapineuzumab for mild to moderate Alzheimer’s disease: a meta-analysis of randomized controlled trials
von: Abdelrahman Ibrahim Abushouk, et al.
Veröffentlicht: (2017-04-01)

A long-term comparison of galantamine and donepezil in the treatment of Alzheimer's disease.
von: Wilcock, G, et al.
Veröffentlicht: (2003)

Evidence-based pharmacotherapy of Alzheimer's disease.
von: Evans, J, et al.
Veröffentlicht: (2004)

Efficacy of Memantine, Donepezil, or Their Association in Moderate-Severe Alzheimer’s Disease: A Review of Clinical Trials
von: Ivana Molino, et al.
Veröffentlicht: (2013-01-01)

Progressive cholinergic decline in Alzheimer's Disease: consideration for treatment with donepezil 23 mg in patients with moderate to severe symptomatology
von: Cummings Jeffrey, et al.
Veröffentlicht: (2011-02-01)

Meta-Analysis of Randomized Controlled Trials on the Efficacy and Safety of Donepezil, Galantamine, Rivastigmine, and Memantine for the Treatment of Alzheimer’s Disease
von: Dan-Dan Li, et al.
Veröffentlicht: (2019-05-01)

CYP2D6 Predicts Plasma Donepezil Concentrations in a Cohort of Thai Patients with Mild to Moderate Dementia
von: Chamnanphon M, et al.
Veröffentlicht: (2020-11-01)

Donepezil enhances frontal functional connectivity in Alzheimer's Disease: a pilot study
von: Griffanti, L, et al.
Veröffentlicht: (2016)

DOMINO-AD protocol: donepezil and memantine in moderate to severe Alzheimer's disease - a multicentre RCT.
von: Jones, R, et al.
Veröffentlicht: (2009)

Donepezil Enhances Frontal Functional Connectivity in Alzheimer's Disease: A Pilot Study
von: Ludovica Griffanti, et al.
Veröffentlicht: (2016-10-01)

Efficacy and safety of galantamine in patients with mild to moderate Alzheimer's disease: multicentre randomised controlled trial. Galantamine International-1 Study Group.
von: Wilcock, G, et al.
Veröffentlicht: (2000)

Obsessive–compulsive disorder induced by donepezil in a patient with Alzheimer's disease
von: Kohei Echizen, et al.
Veröffentlicht: (2024-06-01)

The conceptual relevance of assessment measures in patients with mild/mild‐moderate Alzheimer's disease
von: Ann Hartry, et al.
Veröffentlicht: (2018-01-01)

Erratum: Efficacy and safety of galantamine in patients with mild to moderate Alzheimer's disease: Multicentre randomised controlled trial (British Medical Journal (December 9) (1445-1449))
von: Wilcock, G
Veröffentlicht: (2001)

Erratum: Efficacy and safety of galantamine in patients with mild to moderate Alzheimer's disease: Multicentre randomised controlled trial (British Medical Journal (December 9)(1445-1449))
von: Wilcock, G
Veröffentlicht: (2001)

Velnacrine for Alzheimer's disease.
von: Birks, J, et al.
Veröffentlicht: (2004)

DOMINO-AD protocol: donepezil and memantine in moderate to severe Alzheimer's disease – a multicentre RCT
von: Lindesay James, et al.
Veröffentlicht: (2009-07-01)

Neuropsychological Rehabilitation in Mild and Moderate Alzheimer’s Disease Patients
von: Renata Ávila, et al.
Veröffentlicht: (2007-01-01)